U.S. senators ask Major League Baseball to quit tobacco
Citing the recent announcement by Washington Nationals pitcher Steven Strasburg about the dangers of smokeless tobacco in Major League Baseball (MLB), U.S. Sens. Frank Lautenberg
Citing the recent announcement by Washington Nationals pitcher Steven Strasburg about the dangers of smokeless tobacco in Major League Baseball (MLB), U.S. Sens. Frank Lautenberg
One of the most important genes in the human genome is called p53 and its function is to suppress tumors, according to Roger Leng, PhD,
Tongue cancer patients who have compartmental tongue surgery live longer and have fewer recurrences of the disease compared with those who undergo conventional surgery, a
Transoral laser microsurgery (TLM) is a promising, minimally invasive alternative for treating advanced oropharyngeal cancer, according to researchers from the Washington University School of Medicine
Although tobacco- and alcohol-associated head and neck cancers are declining in many parts of the world, human papillomavirus (HPV)-associated oropharyngeal cancer rates are on the
Raman spectroscopy, a laser-based optical technique that creates a biochemical “fingerprint” of tissue samples, could dramatically improve the ability to detect head and neck cancer
A team of researchers from Clarkson University have discovered a method of making the brightest ever synthesized fluorescent silica nanoparticles. These nanoparticles have potential applications
Salivary metabolomes — the complete set of small-molecule metabolites, such as hormones and other signaling molecules, found in a biological sample — can aid in
Using a new surgical approach, surgeons rebuilt the trachea and preserved a patient’s voice after removing an invasive throat tumor, according to a case study
Renowned movie critic Roger Ebert will unveil a new prosthetic jaw crafted for him by a maxillofacial prosthodontist on his latest TV show, “Ebert Presents
Odontoblast cells, part of the human body’s natural immune system, also fight to protect teeth from decay, according to new research published in BMC Immunology
Biotechnology giant Amgen has agreed to acquire BioVex Group, a privately held biotechnology company that is developing OncoVex, a novel oncolytic vaccine to treat head